Longview Partners Portfolio holdings
Longview Partners is a specialist global equity manager that holds a concentrated portfolio of world stocks, using the same philosophy since it started in 2001. It looks for high-quality businesses that can build value steadily over time, wants a margin of safety on price, and relies on picking individual stocks rather than steering the overall portfolio. Its clients are institutions, and Northill Capital is its majority shareholder.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street
STT
|
+$339M |
| 2 |
Pediatrix Medical
MD
|
+$68.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TE Connectivity
TEL
|
+$395M |
| 2 |
Dollar General
DG
|
+$94.9M |
| 3 |
Parker-Hannifin
PH
|
+$78.8M |
| 4 |
Progressive
PGR
|
+$61.8M |
| 5 |
Aon
AON
|
+$55.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 28.88% |
| 2 | Financials | 26.01% |
| 3 | Technology | 21.72% |
| 4 | Industrials | 16.31% |
| 5 | Consumer Discretionary | 4.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
Aon
AON
$71.8B
| $782M | 5.08% |
6,585,387
-482,600
| -7% | -$55.7M |
2013 Q2
15 quarters
|
|
2
HCA Healthcare
HCA
$104B
| $771M | 5.02% |
8,666,856
-510,193
| -6% | -$42.5M |
2013 Q3
14 quarters
|
|
|
3
Parker-Hannifin
PH
$121B
| $765M | 4.98% |
4,772,882
-519,290
| -10% | -$78.8M |
2015 Q2
7 quarters
|
|
4
Aptiv
APTV
$7.84B
| $762M | 4.96% |
9,472,595
-525,323
| -5% | -$39.4M |
2013 Q2
15 quarters
|
|
5
Zimmer Biomet
ZBH
$19.5B
| $746M | 4.85% |
6,291,783
-344,634
| -5% | -$39.1M |
2015 Q3
6 quarters
|
|
6
Bank of New York Mellon
BNY
$103B
| $746M | 4.85% |
15,792,286
-931,000
| -6% | -$43.5M |
2013 Q2
15 quarters
|
|
|
7
Progressive
PGR
$137B
| $725M | 4.72% |
18,511,772
-1,618,994
| -8% | -$61.8M |
2015 Q1
8 quarters
|
|
8
Emerson Electric
EMR
$91.3B
| $724M | 4.71% |
12,097,338
-681,960
| -5% | -$40.7M |
2015 Q1
8 quarters
|
|
9
Fidelity National Information Services
FIS
$15.2B
| $723M | 4.7% |
9,076,014
-492,450
| -5% | -$39.6M |
2013 Q2
15 quarters
|
|
10
UnitedHealth
UNH
$365B
| $715M | 4.65% |
4,359,337
-252,716
| -5% | -$41.4M |
2014 Q1
12 quarters
|
|
11
Oracle
ORCL
$391B
| $693M | 4.51% |
15,530,569
-786,900
| -5% | -$32.8M |
2013 Q2
15 quarters
|
|
12
Willis Towers Watson
WTW
$30.9B
| $663M | 4.31% |
5,066,287
-241,509
| -5% | -$30.7M |
2016 Q2
3 quarters
|
|
13
Wells Fargo
WFC
$258B
| $663M | 4.31% |
11,907,673
-612,600
| -5% | -$34.8M |
2013 Q2
15 quarters
|
|
14
IQVIA
IQV
$43.7B
| $661M | 4.3% |
8,205,921
-266,845
| -3% | -$20.8M |
2016 Q4
1 quarter
|
|
15
W.W. Grainger
GWW
$69.7B
| $659M | 4.29% |
2,831,758
-157,426
| -5% | -$38.8M |
2015 Q4
5 quarters
|
|
16
Thermo Fisher Scientific
TMO
$259B
| $640M | 4.16% |
4,166,951
-200,575
| -5% | -$30.7M |
2015 Q3
6 quarters
|
|
17
Accenture
ACN
$148B
| $634M | 4.12% |
5,289,311
-266,870
| -5% | -$31.9M |
2013 Q2
15 quarters
|
|
18
Pfizer
PFE
$165B
| $591M | 3.84% |
18,212,607
-771,001
| -4% | -$24.3M |
2013 Q2
15 quarters
|
|
19
Fiserv Inc
FISV
$33.9B
| $573M | 3.72% |
9,931,276
-834,724
| -8% | -$46.9M |
2013 Q2
15 quarters
|
|
|
20
TE Connectivity
TEL
$62B
| $360M | 2.34% |
4,823,419
-5,365,510
| -53% | -$395M |
2013 Q2
15 quarters
|
|
|
TMX
21
DELISTED
Terminix Global Holdings, Inc.
TMX
| $359M | 2.34% |
12,852,146
-666,102
| -5% | -$17.3M |
2016 Q2
3 quarters
|
|
|
22
State Street
STT
$47.2B
| $341M | 2.22% |
+4,279,400
| New | +$339M |
2017 Q1
0 quarters
|
|
23
Omnicom Group
OMC
$24B
| $327M | 2.12% |
3,787,409
-195,392
| -5% | -$16.7M |
2014 Q1
12 quarters
|
|
|
24
Pediatrix Medical
MD
$2.45B
| $316M | 2.06% |
4,555,631
+980,081
| +27% | +$68.1M |
2016 Q4
1 quarter
|
|
25
Arrow Electronics
ARW
$9.8B
| $196M | 1.28% |
2,676,226
-159,649
| -6% | -$11.7M |
2013 Q2
15 quarters
|
|
Similar funds
Longview Partners's Q1 2017 Portfolio in Review
As of Q1 2017, Longview Partners held 28 positions worth $15.4B, up 1.6% from $15.1B the previous quarter. Its ten largest holdings account for 49% of the portfolio.
Longview Partners withdrew a net $914M in Q1 2017, closing 1 position and reducing 25 holdings. Its most notable exit was Dollar General, an estimated $94.9M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 29% of assets, up from 28% a quarter earlier, followed by Financials and Technology.
Against the trend, Longview Partners opened a new position in State Street worth $341M.
- Longview Partners's largest Q1 2017 buy was State Street: 4,279,400 shares worth $341M.
- Longview Partners added most to Pediatrix Medical in Q1 2017, an estimated $68.1M increase.
- Longview Partners's biggest Q1 2017 reduction was TE Connectivity, cutting an estimated $395M.
- Longview Partners fully exited Dollar General in Q1 2017, selling an estimated $94.9M.
- Longview Partners's ten largest holdings make up 49% of its $15.4B portfolio in Q1 2017.
- Longview Partners opened 1 new position and closed 1 in Q1 2017.
- Longview Partners's portfolio value rose 1.6% quarter-over-quarter to $15.4B.
Based on Longview Partners's 13F filing for Q1 2017, filed 8 May 2017.